Altis Biosystems: Funding, Investors & Team (Oct 2026)
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modeling, precision medicine, microbiome research, and compound screening.
Altis Biosystems has raised $1.4M across 2 funding rounds on record, the most recent a Series A announced in Jan 2024.
Altis Biosystems Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Altis Biosystems Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Altis Biosystems raised $1.4M in an undisclosed round announced in Aug 2022.
1.4 years later, a Series A was announced in Jan 2024 with no disclosed amount.
Altis Biosystems Founders and Leadership Team
Contact details for the Altis Biosystems team: 1 of 2 have an email address on file.
Start 14-day free trial →Altis Biosystems Funding Compared to Other Biotechnology Startups
Funded Startups Like Altis Biosystems in Biotechnology and Durham
Companies Similar to Altis Biosystems
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Altis Biosystems Funding FAQs
What does Altis Biosystems do?
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries. The company has developed a patent-pending stem cell technology recreating the human intestinal epithelium for compound screening and microbiome research. Their organ on a chip product produces a layer of human or animal intestinal stem and differentiated cells, either of the small or large intestine. These cells can be used for disease modeling, precision medicine, microbiome research, and compound screening.
How much funding has Altis Biosystems raised?
Altis Biosystems has raised $1.4M across 2 rounds on record.
When did Altis Biosystems last raise funding?
Altis Biosystems' most recent funding round on record was announced in Jan 2024. The amount was not disclosed.
Who founded Altis Biosystems?
FundedIQ lists Ben Scruggs (Founder) at Altis Biosystems.
Who is the CEO of Altis Biosystems?
Michael Biron is listed as CEO at Altis Biosystems.
Where is Altis Biosystems headquartered?
Altis Biosystems is based in Durham, North Carolina, United States.
How many employees does Altis Biosystems have?
Altis Biosystems is in the 11-50 employee band.
About FundedIQ's Altis Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Altis Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.